Diagnostics Pipeline: More AI-Reliant Platforms Being Approved by the FDA
Such assays rely more on imaging and computer power than tissue samples to make diagnoses.
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Such assays rely more on imaging and computer power than tissue samples to make diagnoses.
How clinical laboratories can get started in automation—and what to consider when doing so.
Laboratory leader Ihab Abumuhor discusses recent lab automation-related developments and the keys to successful implementation.
As technology advances and testing demand grows, automation and AI are increasingly making their way into the clinical lab.
Once confined to areas such as pregnancy testing, these assays can now be used to detect STIs and other health issues.
Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Several methods are being developed that improve the ability to rapidly identify organisms and report susceptibility results.
A brief overview of antimicrobial susceptibility testing, current methods used, and new methods on the horizon.
Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?